중만분소환 추출물이 Palmitate로 유발된 비알코올성 지방간 HepG2 cell 모델에 미치는 영향
Effect of Jungmanbunso-hwan Extract on HepG2 Cell Model of Nonalcoholic Fatty Liver Disease Caused by Palmitate
2
조회
0
다운로드
3
인용
0
참고문헌
키워드
초록
Objectives: This study was performed to investigate the anti-lipogenic effect and the mechanism of Jungmanbunso-hwan extract (JMBSH) on a cellular model of non-alcoholic fatty liver disease (NAFLD) caused by palmitate in HepG2 cells. Methods: The JMBSH was prepared, andHepG2 cells were treated with various concentrations of JMBSH in order to perform an MTT assay. The HepG2 cells were cultivated in palmitate-containing media with or without extract of JMBSH. The intracellular lipid content in the HepG2 cells was examined. The effects of JMBSH on sterol regulatory element-binding transcription factor-1c (SREBP-1c), acetyl-CoA carboxylase (ACC), fatty acid synthase (FAS), stearoyl-CoA desaturase-1 (SCD-1), and AMP-activated protein kinase (AMPK) activation in HepG2 cells were measured. Results: JMBSH did not reduce HepG2 cell viability under 1,000 μg/mL. JMBSH considerably decreased intracellular lipid accumulation caused by palmitate in HepG2 cells. JMBSH repressed expression of SREBP-1c, which mediates the induction of lipogenic genes (ACC, FAS, and SCD-1). JMBSH also activated AMPK, which plays animportant role in the regulation of hepatic lipid metabolism. Conclusions: This study suggested that JMBSH relieves hepatic steatosis by repressing SREBP-1c, which mediates the induction of lipogenic genes. The anti-lipogenic effect of JMBSH may also be related to the activation of AMPK. Therefore, JMBSH could potentially be applied to NAFLD treatment after further clinical studies.
Abstract
Objectives: This study was performed to investigate the anti-lipogenic effect and the mechanism of Jungmanbunso-hwan extract (JMBSH) on a cellular model of non-alcoholic fatty liver disease (NAFLD) caused by palmitate in HepG2 cells. Methods: The JMBSH was prepared, andHepG2 cells were treated with various concentrations of JMBSH in order to perform an MTT assay. The HepG2 cells were cultivated in palmitate-containing media with or without extract of JMBSH. The intracellular lipid content in the HepG2 cells was examined. The effects of JMBSH on sterol regulatory element-binding transcription factor-1c (SREBP-1c), acetyl-CoA carboxylase (ACC), fatty acid synthase (FAS), stearoyl-CoA desaturase-1 (SCD-1), and AMP-activated protein kinase (AMPK) activation in HepG2 cells were measured. Results: JMBSH did not reduce HepG2 cell viability under 1,000 μg/mL. JMBSH considerably decreased intracellular lipid accumulation caused by palmitate in HepG2 cells. JMBSH repressed expression of SREBP-1c, which mediates the induction of lipogenic genes (ACC, FAS, and SCD-1). JMBSH also activated AMPK, which plays animportant role in the regulation of hepatic lipid metabolism. Conclusions: This study suggested that JMBSH relieves hepatic steatosis by repressing SREBP-1c, which mediates the induction of lipogenic genes. The anti-lipogenic effect of JMBSH may also be related to the activation of AMPK. Therefore, JMBSH could potentially be applied to NAFLD treatment after further clinical studies.
참고문헌 (39)
- Sourianarayanane A, "Management of non-alcoholic fatty liver disease", Minerva Gastroenterol Dietol, 59(1), pp.69~87 (2013)
- Masuoka HC, "Nonalcoholic fatty liver disease: an emerging threat to obese and diabetic individuals", Ann N Y Acad Sci, 1281, pp.106~122 (2013)
- Brunt EM, "Nonalcoholic steatohepatitis:a proposal for grading and staging the histological lesions", Am J Gastroenterol, 94(9), pp.2467~2474 (1999)
- Influence of dietary intake on non-alcoholic fatty liver disease in Korean, "Jun DW", National Institute of Food and Drug Safety Evaluation, 1~188 (2012)
- Beaton MD, "Current treatment options for nonalcoholic fatty liver disease and nonalcoholic steatohepatitis", Can J Gastroenterol, 26(6), pp.353~357 (2012)
- Shyangdan D, "Insulin sensitisers in the treatment of non-alcoholic fatty liver disease:a systematic review", Health Technol Assess, 15(38), pp.1~110 (2011)
- Professors of Department of Internal Medicine of liver system, National College of Korean Medicine, "Gangye Naegwahak", pp.102~115 (2013), Nado
- Lee G, "Nansilbijang", pp.15~ (1994), Euiseongdang
- Lee C, "Euhak Ibmun", pp.1808~ (2009), Beop In publishing company
- Joo JH, "Dangyesimbeop Buyeo(new edition)", pp.298~ (1993), Dae Seong publishing company
- Woo D, "Euhak Jeongjeon", pp.143~144 (1986), Seongbosa
- Jin JP, "Manbyeong Hoichun(paginal translation)", pp.391~392 (2007), Beop In publishing company
- Heo J, "Dongui Bogam(paginal translation)", pp.1434~ (2010), Dongui Bogam publishing company
- Wang A, "Uibang Jiphae", pp.398~400 (1992), Dae Seong publishing company
- Lee YU, "The effect of Chungmanbunso-whoan on mouse hepatocyte damages induced by paraquat", Journal of Korean Medicine, 20(3), pp.18~26 (1999)
- Repa JJ, "Regulation of mouse sterol regulatory element-binding protein-1c gene(SREBP-1c) by oxysterol receptors, LXRalpha and LXRbeta", Genes Dev, 14(22), pp.2819~2830 (2000)
- Zhou G, "Role of AMP-activated protein kinase in mechanism of metformin action", J Clin Invest, 108(8), pp.1167~1174 (2001)
- Lin HZ, "Metformin reverses fatty liver disease in obese, leptin-deficient mice", Nat Med, 6(9), pp.998~1003 (2000)
- Choi WC, "Nonalcoholic Fatty Liver disease", Inje Medical J, 23(2), pp.217~224 (2002)
- Amgulo, P, "Nonalcoholic fatty liver dusease", New England journal Med, 346, pp.1221~1231 (2002)
- Sheth SG, "Nonalcoholic steatohepatitis", Ann Intern Med, 126, pp.137~145 (1997)
- Park SH, "Nonalcoholic steatohepatitis: Pathogenesis and treatment", Korean J Hepatol, 14(1), pp.12~27 (2008)
- 한창우, "비알코올성 지방간 세포 모델에 대한 택사, 산사, 구기자, 울금, 단삼, 인진의 효능 비교", 대한한방내과학회지, 33(4), pp.533~542 (2012), 대한한방내과학회
- 장영숙, "적소두가 비알코올성 지방간 질환 세포 모델에 미치는 효과", 동의생리병리학회지, 27(6), pp.802~809 (2013), 한의병리학회
- 최준용, "동과자 에탄올 추출물이 비알코올성 지방간 세포 모델에 미치는 효과", 대한한방내과학회지, 33(4), pp.438~447 (2012), 대한한방내과학회
- 김소연, "비알코올성 지방간 세포 모델에서 곤포의 효능과 기전 연구", 대한한방내과학회지, 35(2), pp.175~183 (2014), 대한한방내과학회
- 최미영, "加味生肝湯이 고지방식이로 유발된 지방간에 미치는 영향", 대한한방내과학회지, 30(2), pp.365~374 (2009), 대한한방내과학회
- 신순식, "감비경신환(1)에 의한 고지방식이 비만동물모델에서 체중감량과 지질대사의 조절", 대한본초학회지, 29(1), pp.35~43 (2014), 대한본초학회
- 노종성, "고지방식이 유도 비알콜성지방간 마우스 모델에서 六神麯의 脂肪肝 개선효과", 대한본초학회지, 29(2), pp.23~31 (2014), 대한본초학회
- Department of Internal Medicine of kidney system, National College of Korean Medicine, "Syngye Naegwahak", pp.89~96 (2011), Gunja publishing company
- Gwon GH, "Huang Di Nei Jing (Editing)", pp.21~ (2005), Banryong
- Jo HG, "The Bibliographical Study on Causes, Mechanisms and the Chief Virtues on Obesity", Collected papers of Institute of Oriental medicine, 1(2), pp.61~71 (1992)
- Bang HJ, "Korean medical consideration of hyperlipidemia", The J of East-West medicines, 20(1), pp.25~36 (1995)
- Kola B, "The role of AMP-activated protein kinase in obesity", Front Horm Res, 36, pp.198~211 (2008)
- Winder WW, "AMP-activated protein kinase, a metabolic master switch: possible roles in type 2 diabetes", Am J Physiol, 277(1 Pt 1), pp.E1~E10 (1999)
- Park H, "Coordinate regulation of malonyl-CoA decarboxylase, sn-glycerol-3-phosphate acyltransferase, and acetyl-CoA carboxylase by AMPK in rat tissues in response to exercise", J Biol Chem, 277(36), pp.32571~32577 (2002)
- Kawaguchi T, "Mechanism for fatty acid “sparing" effect on glucose-induced transcription:regulation of carbohydrate-responsive elementbinding protein by AMP-activated protein kinase", J Biol Chem, 277(6), pp.3829~3835 (2002)
- Muoio DM, "AMP-activated kinase reciprocally regulates triacylglycerol synthesis and fatty acid oxidation in liver and muscle: evidence that sn-glycerol-3-phosphate acyltransferase is a novel target", Biochem J, 338(Pt3), pp.783~791 (1999)
- Clarke PR, "Regulation of HMG-CoA reductase: identification of the site phosphorylated by the AMP-activated protein kinase in vitro and in intact rat liver", EMBO J, 9(8), pp.2439~2446 (1990)
